Hi @Footmax glad to see you have a bit of sense of humour. I was quite placid until I got accused of down ramping then had RLT attacked in every response rather than answering some pretty fair questions.
I meant no ill will by the posts. Sorry if they come across as aggressive. I agreed the P50 target is 3BCF valued at $840M. You'll note even when I discuss RLT I use the P90 figure to be conservative, so I wasn't giving BNL harsh treatment using that P90 figure earlier on.
Was genuinely trying to understand what might be at play to explain how BNL has rallied 1000% on a P50 estimate of 3BCF, whilst RLT with a P50 estimate of 106BCF has done nothing. You are all correct in pointing out it's SP is woeful with zero demand, I agree. BNL would have been a much more profitable bet 3 months ago. I'm here to see what BNL do differently to RLT. Again it is a testament to the BNL management how they have promoted the stock and generated such demand.
I'll leave it at that.
- Forums
- ASX - By Stock
- BNL
- A Good Summary
A Good Summary, page-283
-
-
- There are more pages in this discussion • 120 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BNL (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.47M |
Open | High | Low | Value | Volume |
0.5¢ | 0.5¢ | 0.4¢ | $4.018K | 886.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 5598437 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 23148949 | 18 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 5598437 | 0.004 |
56 | 52209200 | 0.003 |
23 | 16480702 | 0.002 |
8 | 21733025 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 23148949 | 18 |
0.006 | 8988578 | 11 |
0.007 | 2675712 | 5 |
0.008 | 3232125 | 7 |
0.009 | 3642970 | 5 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
BNL (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online